Santosh Kesari graduated from University of Pennsylvania School of Arts and Sciences, Philadelphia, PA, USA, in 1992 and earned a Ph.D. degree in molecular biology and a M.D. from the University of Pennsylvania School of Medicine, Philadelphia, PA, USA. He completed his residency in neurology at the Massachusetts General Hospital, Boston, MA, USA/Brigham and Women’s Hospital, Boston, MA, USA/Harvard Medical School, Boston, MA, USA, and his neurooncology Fellowship at the Dana-Farber Cancer Institute in Boston, MA, USA. He was previously Assistant Professor of neurology at Harvard Medical School/Dana-Farber Cancer Institute/Brigham and Women’s Hospital and then professor of neurosciences at UC San Diego, San Diego, CA, USA. He is a Member of the Society of Neuro-Oncology, American Society of Clinical Oncology, Indian Society of Neuro-Oncology, American Neurological Association, and American Academy of Neurology. Dr. Kesari is a board-certified neurologist and neurooncologist and is currently Chair, Department of Translational Neuro-Oncology and Neurotherapeutics, John Wayne Cancer Institute, Santa Monica, CA, USA. He is also Director of Neuro-Oncology, Providence Saint John’s Health Center and Member, Los Angeles Biomedical Research Institute, Inglewood, CA, USA. Dr. Kesari is ranked among the top 1% of neurooncologists and neurologists in the nation, according to Castle Connolly Medical Ltd., New York, NY, USA, and an internationally recognized scientist and clinician. He is a winner of an Innovation Award by the San Diego Business Journal. He is on the advisory board of American Brain Tumor Association, San Diego Brain Tumor Foundation, Chris Elliott Fund, Nicolas Conor Institute, Voices Against Brain Cancer, and Philippine Brain Tumor Alliance. He has been the author of over 250 scientific publications, reviews, or books. He is the inventor on several patents and patent applications and founder and advisor to many cancer and neurosciences focused biotech startups.
Biography Updated on 5 April 2016